Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
MEDANTA
Dr. Naresh Kumar Trehan · Gurugram, India
₹1,432.90
▲+2.26%MEDANTA is trading near its 52-week high with strong revenue growth but at a premium valuation, reflecting positive sentiment toward its healthcare services expansion.
Exchange
NSI
Currency
INR
Day range
₹1,394.30 – ₹1,438.00
52-week range
₹956.00 – ₹1,456.50
Sector
Healthcare
Industry
Medical Care Facilities
AI investment rating
AI analysis75% confidence
The stock appears overvalued at current levels given its high P/E ratio of 69.56, though premium could be justified by strong revenue growth and expansion plans.
1.6% below the 1-year high · trend up
Hedge-fund memo
Today
Up 2.26%, trading near 52-week high with strong volume
This week
Continued upward momentum testing resistance at 1456.5
This month
Strong performance outperforming broader healthcare index
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Neutral
24 headlines · 21 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 2 of 4 recent quarters (EPS actual vs. consensus).
5.35 vs 4.36667
22.52% surprise
4.6217 vs 5.33333
-13.34% surprise
5.4232 vs 6
-9.61% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| MEDANTA | 385.05B | 69.56 | 15.03% | 15.29% | 24.50% |
| RAINBOW | 154.16B | 55.52 | 17.94% | 22.56% | 24.30% |
| MANKIND | 1.07T | 55.95 | 12.45% |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 498sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Regulatory changes affecting healthcare pricing
Mitigation: Diversification across service lines and geographies
High valuation multiple
Mitigation: Focus on long-term growth rather than short-term price movements
Business intelligence
Competitive moat
Strong brand recognition and multi-specialty healthcare ecosystem creating referral network advantage
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
New hospital facility announcements
Revenue growth confirmation
Thesis builder
Bull case
Strong revenue growth and expansion plans could justify premium valuation
Base case
Maintains steady profitability with 12.62% margins and 15.03% ROE
Bear case
High valuation could lead to correction if growth slows
Time horizon
12-18 months
Est. CAGR
15-20%
Entry (qual.)
On dips below 1300
Exit (qual.)
Above 1600 or if growth decelerates below 15%
Overall conviction 75%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how MEDANTA fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain MEDANTA for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
Buy for long-term growth but be prepared for volatility given premium valuation
The News Mill·1d ago·high-profile patient transfer
thehawk.in·2d ago·preferred hospital for VIPs
businessnewsthisweek.com·2d ago·preventive healthcare initiative
timesofindia.indiatimes.com·2d ago·patient discharge normal
Telugu Times·3d ago·reputation for VIP treatment
indiatribune.com·3d ago·unspecified hospital discharge
The News Mill·3d ago·patient transfer to Medanta
news.abplive.com·3d ago·discharge unrelated to Medanta
t.co·3d ago·discharge unrelated to Medanta
Daily Pioneer·3d ago·discharge unrelated to Medanta
news9live.com·3d ago·unspecified hospital discharge
Odisha TV·3d ago·discharge unrelated to Medanta
Outlook India·3d ago·unspecified hospital discharge
The Hindu·3d ago·patient discharge normal
ETV Bharat·3d ago·unspecified hospital discharge
WION·3d ago·discharge unrelated to Medanta
Times Now·3d ago·discharge after long stay
NewsBytes·3d ago·discharge after long stay
Mid-Day·3d ago·ongoing patient care
Indian Pharma Post·3d ago·community wellness program
Mid-Day·3d ago·discharge after long stay
newindianexpress.com·3d ago·discharge unrelated to Medanta
thehawk.in·3d ago·unspecified hospital discharge
theweek.in·3d ago·discharge unrelated to Medanta
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
5.3594 vs 4.81333
11.34% surprise
| 23.08% |
| 11.80% |
| KIMS | 322.91B | 133.17 | 9.72% | 11.50% | 34.80% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹1,394.30
Resistance (day/52w high)
₹1,438.00
Volume
2,45,801
Trend
up
RSI (14)
72
MACD
bullish
MA cross
golden
50-day MA
₹1,285.65
200-day MA
₹1,187.87
vs 200-DMA
20.6%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.